• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新评估重症监护研究中的无呼吸机天数。

Reappraisal of Ventilator-Free Days in Critical Care Research.

机构信息

Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Department of Anesthesiology and Critical Care Medicine.

出版信息

Am J Respir Crit Care Med. 2019 Oct 1;200(7):828-836. doi: 10.1164/rccm.201810-2050CP.

DOI:10.1164/rccm.201810-2050CP
PMID:31034248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6812447/
Abstract

Ventilator-free days (VFDs) are a commonly reported composite outcome measure in acute respiratory distress syndrome trials. VFDs combine survival and duration of ventilation in a manner that summarizes the "net effect" of an intervention on these two outcomes. However, this combining of outcome measures makes VFDs difficult to understand and analyze, which contributes to imprecise interpretations. We discuss the strengths and limitations of VFDs and other "failure-free day" composites, and we provide a framework for when and how to use these outcome measures. We also provide a comprehensive discussion of the different analytic methods for analyzing and interpreting VFDs, including Student's tests and rank-sum tests, as well as competing risk regressions treating extubation as the primary outcome and death as the competing risk. Using simulations, we illustrate how the statistical test with optimal power depends on the relative contributions of mortality and ventilator duration on the composite effect size. Finally, we recommend a simple analysis and reporting framework using the competing risk approach, which provides clear information on the effect size of an intervention, a statistical test and measure of confidence with the ability to adjust for baseline factors and allow interim monitoring for trials. We emphasize that any approach to analyzing a composite outcome, including other "failure-free day" constructs, should also be accompanied by an examination of the components.

摘要

无呼吸机天数(VFDs)是急性呼吸窘迫综合征试验中常用的综合预后指标。VFDs 将存活率和通气持续时间结合在一起,以总结干预对这两个结果的“净效应”。然而,这种将预后指标结合在一起的方法使得 VFDs 难以理解和分析,从而导致解释不精确。我们讨论了 VFDs 和其他“无失败日”综合指标的优缺点,并提供了何时以及如何使用这些预后指标的框架。我们还全面讨论了分析和解释 VFDs 的不同分析方法,包括学生 t 检验和秩和检验,以及将拔管作为主要结局并将死亡作为竞争风险的竞争风险回归。通过模拟,我们说明了具有最佳功效的统计检验如何取决于死亡率和通气持续时间对复合效应大小的相对贡献。最后,我们建议使用竞争风险方法进行简单的分析和报告框架,该框架提供了有关干预效果大小、统计检验和置信度度量的明确信息,具有调整基线因素和允许进行试验中期监测的能力。我们强调,任何分析综合预后的方法,包括其他“无失败日”结构,都应伴随着对组成部分的检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d552/6812447/c102cfa6e994/rccm.201810-2050CP_f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d552/6812447/a12b26c2a5ef/rccm.201810-2050CP_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d552/6812447/c102cfa6e994/rccm.201810-2050CP_f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d552/6812447/a12b26c2a5ef/rccm.201810-2050CP_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d552/6812447/c102cfa6e994/rccm.201810-2050CP_f2.jpg

相似文献

1
Reappraisal of Ventilator-Free Days in Critical Care Research.重新评估重症监护研究中的无呼吸机天数。
Am J Respir Crit Care Med. 2019 Oct 1;200(7):828-836. doi: 10.1164/rccm.201810-2050CP.
2
Alive and Ventilator Free: A Hierarchical, Composite Outcome for Clinical Trials in the Acute Respiratory Distress Syndrome.存活且无需呼吸机:急性呼吸窘迫综合征临床试验的分层综合结局。
Crit Care Med. 2020 Feb;48(2):158-166. doi: 10.1097/CCM.0000000000004104.
3
Ventilator-Free Day Outcomes Can Be Misleading.无呼吸机日结局可能具有误导性。
Crit Care Med. 2018 Mar;46(3):425-429. doi: 10.1097/CCM.0000000000002890.
4
Effects of Methylprednisolone on Ventilator-Free Days in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome and COVID-19: A Retrospective Study.甲泼尼龙对急性呼吸窘迫综合征合并新型冠状病毒肺炎机械通气患者无呼吸机天数的影响:一项回顾性研究
J Clin Med. 2021 Feb 14;10(4):760. doi: 10.3390/jcm10040760.
5
Sample size estimation in clinical trials using ventilator-free days as the primary outcome: a systematic review.临床试验中以呼吸机使用天数为主要结局指标的样本量估计:系统综述。
Crit Care. 2023 Aug 1;27(1):303. doi: 10.1186/s13054-023-04562-y.
6
Co-ordinated multidisciplinary intervention to reduce time to successful extubation for children on mechanical ventilation: the SANDWICH cluster stepped-wedge RCT.多学科协调干预以缩短机械通气患儿成功拔管时间:SANDWICH 集群 stepped-wedge RCT。
Health Technol Assess. 2022 Mar;26(18):1-114. doi: 10.3310/TCFX3817.
7
Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.地塞米松治疗 ARDS 合并 COVID-19 患者的效果 - 一项前瞻性、多中心、开放标签、平行组、随机对照试验(REMED 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 1;22(1):172. doi: 10.1186/s13063-021-05116-9.
8
Association of early positive end-expiratory pressure settings with ventilator-free days in patients with coronavirus disease 2019 acute respiratory distress syndrome: A secondary analysis of the Practice of VENTilation in COVID-19 study.新冠肺炎急性呼吸窘迫综合征患者早期呼气末正压设置与呼吸机使用天数的关系:COVID-19 通气实践研究的二次分析。
Eur J Anaesthesiol. 2021 Dec 1;38(12):1274-1283. doi: 10.1097/EJA.0000000000001565.
9
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.地塞米松对中重度 COVID-19 相关急性呼吸窘迫综合征患者存活天数和无呼吸机天数的影响:CoDEX 随机临床试验。
JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.
10
Immunonutrition for acute respiratory distress syndrome (ARDS) in adults.成人急性呼吸窘迫综合征(ARDS)的免疫营养
Cochrane Database Syst Rev. 2019 Jan 24;1(1):CD012041. doi: 10.1002/14651858.CD012041.pub2.

引用本文的文献

1
Two-part model for ventilator-free days in a cluster randomized cross-over clinical trial.群组随机交叉临床试验中无呼吸机天数的两部分模型
BMC Med Res Methodol. 2025 Aug 26;25(1):200. doi: 10.1186/s12874-025-02653-8.
2
Beyond the ventilator-free days: review of several estimands.超越无呼吸机天数:几种估计量的综述
Crit Care. 2025 Aug 4;29(1):343. doi: 10.1186/s13054-025-05593-3.
3
Parent and Provider Perspectives on Short-Term Outcomes of Critically Ill Ventilated Children.家长与医护人员对危重症通气儿童短期预后的看法。

本文引用的文献

1
Measuring and Analyzing Length of Stay in Critical Care Trials.测量和分析重症监护试验中的住院时间。
Med Care. 2019 Sep;57(9):e53-e59. doi: 10.1097/MLR.0000000000001059.
2
Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study.儿科急性呼吸窘迫综合征的发病率和流行病学(PARDIE):一项国际性、观察性研究。
Lancet Respir Med. 2019 Feb;7(2):115-128. doi: 10.1016/S2213-2600(18)30344-8. Epub 2018 Oct 22.
3
Epidemiology of Cause of Death in Pediatric Acute Respiratory Distress Syndrome.
Pediatr Crit Care Med. 2025 Jul 22. doi: 10.1097/PCC.0000000000003794.
4
What is the optimal approach to analyse ventilator-free days? A simulation study.分析无呼吸机天数的最佳方法是什么?一项模拟研究。
Crit Care. 2025 Jun 19;29(1):251. doi: 10.1186/s13054-025-05474-9.
5
A New Generation of Clinical Endpoints for Critical Care Trials.重症监护试验的新一代临床终点
Am J Respir Crit Care Med. 2025 Aug;211(8):1326-1329. doi: 10.1164/rccm.202505-1134ED.
6
Multicentre pragmatic embedded stepped wedge cluster randomised trial comparing glucose 5% with sodium chloride 0.9% as the default drug diluent in the ICU: the sweet-water trial protocol.多中心实用嵌入式阶梯楔形整群随机试验:比较5%葡萄糖与0.9%氯化钠作为重症监护病房默认药物稀释剂——“甜水试验”方案
BMJ Open. 2025 Jun 5;15(6):e097361. doi: 10.1136/bmjopen-2024-097361.
7
Optimization of Inspired Oxygen during Mechanical Ventilation (OPTI-OXYGEN): rationale and design of a pragmatic randomised controlled trial.机械通气期间吸入氧优化(OPTI-OXYGEN):一项实用随机对照试验的原理与设计
BMJ Open. 2025 Jun 5;15(6):e094924. doi: 10.1136/bmjopen-2024-094924.
8
Cytomegalovirus reactivation in the lower respiratory tract as an independent risk factor for mortality in critically Ill patients.下呼吸道巨细胞病毒再激活是危重症患者死亡的独立危险因素。
Crit Care. 2025 May 2;29(1):177. doi: 10.1186/s13054-025-05324-8.
9
Impact of Benzodiazepines on Outcomes of Mechanically Ventilated Pediatric Intensive Care Patients: A Retrospective Cohort Study.苯二氮䓬类药物对机械通气的儿科重症监护患者预后的影响:一项回顾性队列研究。
Crit Care Explor. 2025 Apr 28;7(5):e1255. doi: 10.1097/CCE.0000000000001255. eCollection 2025 May 1.
10
Role of Proton Pump Inhibitor as Stress Ulcer Prophylaxis in Sick Children: A Randomized Controlled Trial.质子泵抑制剂在患病儿童应激性溃疡预防中的作用:一项随机对照试验
Indian Pediatr. 2025 Jun;62(6):407-413. doi: 10.1007/s13312-025-00035-3. Epub 2025 Apr 11.
儿科急性呼吸窘迫综合征死亡原因的流行病学。
Crit Care Med. 2018 Nov;46(11):1811-1819. doi: 10.1097/CCM.0000000000003371.
4
Subtypes of pediatric acute respiratory distress syndrome have different predictors of mortality.儿科急性呼吸窘迫综合征的亚型有不同的死亡率预测指标。
Intensive Care Med. 2018 Aug;44(8):1230-1239. doi: 10.1007/s00134-018-5286-6. Epub 2018 Jul 3.
5
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.氢化可的松联合氟氢可的松治疗脓毒性休克成人患者。
N Engl J Med. 2018 Mar 1;378(9):809-818. doi: 10.1056/NEJMoa1705716.
6
Balanced Crystalloids versus Saline in Noncritically Ill Adults.非危重症成年患者使用平衡晶体液与生理盐水的比较。
N Engl J Med. 2018 Mar 1;378(9):819-828. doi: 10.1056/NEJMoa1711586. Epub 2018 Feb 27.
7
Balanced Crystalloids versus Saline in Critically Ill Adults.重症成年患者中平衡晶体液与生理盐水的比较
N Engl J Med. 2018 Mar 1;378(9):829-839. doi: 10.1056/NEJMoa1711584. Epub 2018 Feb 27.
8
Ventilator-Free Day Outcomes Can Be Misleading.无呼吸机日结局可能具有误导性。
Crit Care Med. 2018 Mar;46(3):425-429. doi: 10.1097/CCM.0000000000002890.
9
Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation (MoDUS): a randomised, double-blind, placebo-controlled trial.评价机械通气危重症患者早期应用辛伐他汀预防和治疗谵妄(MoDUS)的随机、双盲、安慰剂对照试验。
Lancet Respir Med. 2017 Sep;5(9):727-737. doi: 10.1016/S2213-2600(17)30234-5. Epub 2017 Jul 19.
10
Durability of Weaning Success for Liberation from Invasive Mechanical Ventilation: An Analysis of a Nationwide Database.有创机械通气脱机成功的持续性:一项全国性数据库分析
Am J Respir Crit Care Med. 2017 Sep 15;196(6):792-795. doi: 10.1164/rccm.201610-2153LE.